$ACUR
ACURA PHARMACEUTICALS, INC

2016 Q3 Form 10-Q Financial Statement

#000114420416134413 Filed on November 14, 2016

View on sec.gov

Income Statement

Concept 2016 Q3 2015 Q4 2015 Q3
Revenue $218.0K $2.679M $210.0K
YoY Change 3.81% 406.43% 44.83%
Cost Of Revenue $110.0K $100.0K $130.0K
YoY Change -15.38% 150.0% 18.18%
Gross Profit $110.0K $2.580M $80.00K
YoY Change 37.5% 426.53% 100.0%
Gross Profit Margin 50.46% 96.3% 38.1%
Selling, General & Admin $1.338M $2.590M $2.024M
YoY Change -33.89% 26.96% 17.13%
% of Gross Profit 1216.36% 100.39% 2530.0%
Research & Development $841.0K $700.0K $430.0K
YoY Change 95.58% -23.08% -54.97%
% of Gross Profit 764.55% 27.13% 537.5%
Depreciation & Amortization $90.00K $90.00K $90.00K
YoY Change 0.0% -52.63% 200.0%
% of Gross Profit 81.82% 3.49% 112.5%
Operating Expenses $2.179M $3.290M $2.024M
YoY Change 7.66% 10.25% -27.48%
Operating Profit -$2.069M -$710.0K -$2.405M
YoY Change -13.97% -71.08% -9.11%
Interest Expense $215.0K -$210.0K $283.0K
YoY Change -24.03% -12.5% -6.91%
% of Operating Profit
Other Income/Expense, Net -$181.0K $0.00 $0.00
YoY Change -100.0%
Pretax Income -$2.250M -$920.0K -$2.649M
YoY Change -15.06% -65.93% -8.78%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.250M -$916.0K -$2.649M
YoY Change -15.06% -66.02% -8.78%
Net Earnings / Revenue -1032.11% -34.19% -1261.43%
Basic Earnings Per Share -$0.19 -$0.08 -$0.23
Diluted Earnings Per Share -$0.19 -$0.08 -$0.23
COMMON SHARES
Basic Shares Outstanding 11.88M shares 11.80M shares 11.68M shares
Diluted Shares Outstanding 11.88M shares 11.68M shares

Balance Sheet

Concept 2016 Q3 2015 Q4 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.270M $13.32M $15.25M
YoY Change -72.0% 10.14% 4.74%
Cash & Equivalents $1.772M $2.485M $3.324M
Short-Term Investments $0.00 $10.84M $11.93M
Other Short-Term Assets $410.0K $2.910M $490.0K
YoY Change -16.33% 321.74% -48.42%
Inventory $424.0K $276.0K $70.00K
Prepaid Expenses
Receivables $169.0K $83.00K $170.0K
Other Receivables $0.00 $40.00K $50.00K
Total Short-Term Assets $5.276M $14.14M $16.03M
YoY Change -67.09% 6.83% -0.68%
LONG-TERM ASSETS
Property, Plant & Equipment $979.0K $1.013M $1.040M
YoY Change -5.87% 5.85% 8.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $180.0K $180.0K
YoY Change -100.0% 0.0%
Total Long-Term Assets $2.462M $2.826M $2.910M
YoY Change -15.4% 0.86% -7.32%
TOTAL ASSETS
Total Short-Term Assets $5.276M $14.14M $16.03M
Total Long-Term Assets $2.462M $2.826M $2.910M
Total Assets $7.738M $16.96M $18.94M
YoY Change -59.14% 5.79% -1.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $403.0K $110.0K $280.0K
YoY Change 43.93% -49.31% 141.38%
Accrued Expenses $736.0K $564.0K $890.0K
YoY Change -17.3% -0.7% -40.19%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.685M $2.320M $2.470M
YoY Change 8.7% 31.97% 112.93%
Total Short-Term Liabilities $4.200M $3.244M $3.840M
YoY Change 9.38% 8.42% 26.65%
LONG-TERM LIABILITIES
Long-Term Debt $3.508M $5.430M $6.040M
YoY Change -41.92% -30.38% -29.19%
Other Long-Term Liabilities $520.0K $390.0K $340.0K
YoY Change 52.94% 105.26% 142.86%
Total Long-Term Liabilities $3.508M $5.430M $6.380M
YoY Change -45.02% -30.38% -26.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.200M $3.244M $3.840M
Total Long-Term Liabilities $3.508M $5.430M $6.380M
Total Liabilities $8.230M $9.061M $10.22M
YoY Change -19.47% -17.48% -12.65%
SHAREHOLDERS EQUITY
Retained Earnings -$367.3M
YoY Change 1.38%
Common Stock $375.7M $375.3M
YoY Change 2.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$490.0K $7.900M $8.730M
YoY Change
Total Liabilities & Shareholders Equity $7.740M $16.96M $18.94M
YoY Change -59.13% 5.79% -1.76%

Cashflow Statement

Concept 2016 Q3 2015 Q4 2015 Q3
OPERATING ACTIVITIES
Net Income -$2.250M -$916.0K -$2.649M
YoY Change -15.06% -66.02% -8.78%
Depreciation, Depletion And Amortization $90.00K $90.00K $90.00K
YoY Change 0.0% -52.63% 200.0%
Cash From Operating Activities -$1.850M -$1.060M -$2.130M
YoY Change -13.15% -54.89% -19.32%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K $0.00 $50.00K
YoY Change -120.0% -100.0% -183.33%
Acquisitions
YoY Change
Other Investing Activities $3.510M $1.020M -$2.310M
YoY Change -251.95% -46.6% -677.5%
Cash From Investing Activities $3.500M $1.020M -$2.260M
YoY Change -254.87% -45.74% -745.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -640.0K -800.0K 6.450M
YoY Change -109.92%
NET CHANGE
Cash From Operating Activities -1.850M -1.060M -2.130M
Cash From Investing Activities 3.500M 1.020M -2.260M
Cash From Financing Activities -640.0K -800.0K 6.450M
Net Change In Cash 1.010M -840.0K 2.060M
YoY Change -50.97% 78.72% -189.96%
FREE CASH FLOW
Cash From Operating Activities -$1.850M -$1.060M -$2.130M
Capital Expenditures -$10.00K $0.00 $50.00K
Free Cash Flow -$1.840M -$1.060M -$2.180M
YoY Change -15.6% -54.31% -15.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1013000 USD
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
979000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1638000 USD
CY2016Q3 us-gaap Assets
Assets
7738000 USD
CY2016Q3 us-gaap Assets Current
AssetsCurrent
5276000 USD
CY2016Q3 us-gaap Inventory Net
InventoryNet
424000 USD
CY2015Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
37000 USD
CY2016Q3 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
0 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
83000 USD
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
169000 USD
CY2015Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
10837000 USD
CY2016Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2485000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4272000 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
564000 USD
CY2016Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
44000 USD
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
45000 USD
CY2016Q3 us-gaap Interest Payable Current
InterestPayableCurrent
44000 USD
CY2015Q4 us-gaap Interest Payable Current
InterestPayableCurrent
0 USD
CY2016Q3 acur Sales Returns Liability Current
SalesReturnsLiabilityCurrent
288000 USD
CY2015Q4 us-gaap Assets
Assets
16961000 USD
CY2016Q3 us-gaap Other Assets
OtherAssets
0 USD
CY2015Q4 us-gaap Other Assets
OtherAssets
175000 USD
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
403000 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
110000 USD
CY2016Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
736000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
14135000 USD
CY2015Q3 us-gaap Costs And Expenses
CostsAndExpenses
2615000 USD
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
118000 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
118000 USD
CY2016Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
375625000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-367310000 USD
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-65000 USD
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
375157000 USD
CY2015Q4 acur Sales Returns Liability Current
SalesReturnsLiabilityCurrent
205000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3244000 USD
CY2016Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3508000 USD
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5430000 USD
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2320000 USD
CY2016Q3 acur Longterm Portion Of Accrued Interest
LongtermPortionOfAccruedInterest
519000 USD
CY2015Q4 acur Longterm Portion Of Accrued Interest
LongtermPortionOfAccruedInterest
387000 USD
CY2016Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2685000 USD
CY2015Q3 us-gaap Royalty Revenue
RoyaltyRevenue
0 USD
us-gaap Royalty Revenue
RoyaltyRevenue
86000 USD
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
115000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
306000 USD
CY2015Q3 us-gaap License And Services Revenue
LicenseAndServicesRevenue
0 USD
us-gaap License And Services Revenue
LicenseAndServicesRevenue
0 USD
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2024000 USD
acur Cost Of Sales Excluding Inventory Write Down
CostOfSalesExcludingInventoryWriteDown
309000 USD
CY2015Q3 us-gaap Inventory Write Down
InventoryWriteDown
27000 USD
us-gaap Inventory Write Down
InventoryWriteDown
26000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3258000 USD
CY2015Q3 acur Cost Of Sales Excluding Inventory Write Down
CostOfSalesExcludingInventoryWriteDown
132000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-2649000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2405000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-8286000 USD
CY2015Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
39000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
59000 USD
CY2015Q3 us-gaap Interest Expense
InterestExpense
283000 USD
us-gaap Interest Expense
InterestExpense
697000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2649000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8922000 USD
CY2015Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
65000 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2647000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8857000 USD
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.75
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.75
us-gaap Royalty Revenue
RoyaltyRevenue
0 USD
CY2016Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
105000 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Costs And Expenses
CostsAndExpenses
8985000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11677000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11858000 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11677000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11858000 shares
CY2015Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
95000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
307000 USD
CY2016Q3 us-gaap Revenues
Revenues
218000 USD
us-gaap Revenues
Revenues
5908000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
563000 USD
CY2016Q3 us-gaap License And Services Revenue
LicenseAndServicesRevenue
0 USD
us-gaap License And Services Revenue
LicenseAndServicesRevenue
5250000 USD
us-gaap Interest Expense
InterestExpense
892000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2250000 USD
CY2016Q3 acur Cost Of Sales Excluding Inventory Write Down
CostOfSalesExcludingInventoryWriteDown
108000 USD
acur Cost Of Sales Excluding Inventory Write Down
CostOfSalesExcludingInventoryWriteDown
554000 USD
CY2016Q3 us-gaap Inventory Write Down
InventoryWriteDown
0 USD
us-gaap Inventory Write Down
InventoryWriteDown
334000 USD
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
841000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1907000 USD
CY2016Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1338000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6404000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2069000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3291000 USD
CY2016Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
11000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
110000 USD
CY2016Q3 us-gaap Interest Expense
InterestExpense
215000 USD
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-26000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4073000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-2250000 USD
us-gaap Net Income Loss
NetIncomeLoss
-4073000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4071000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-181000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-782000 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11880000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10446000 shares
us-gaap Costs And Expenses
CostsAndExpenses
9199000 USD
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2016Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
74000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
461000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
95000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
65000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
450000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
18000 USD
acur Provision To Reduce Inventory To Net Realizable Value
ProvisionToReduceInventoryToNetRealizableValue
26000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
104000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
92000 USD
acur Provision To Reduce Inventory To Net Realizable Value
ProvisionToReduceInventoryToNetRealizableValue
334000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
450000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
113000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
144000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
59000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
170000 USD
acur Amortization Of Bond Premium In Marketable Securities
AmortizationOfBondPremiumInMarketableSecurities
31000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
155000 USD
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-37000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-217000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
293000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7343000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2632000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
257000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-353000 USD
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-15000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
174000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
104000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-9000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
17000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
774000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3324000 USD
us-gaap Interest Paid
InterestPaid
407000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
176000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
141000 USD
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
0 USD
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
1000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1671000 USD
us-gaap Interest Paid
InterestPaid
606000 USD
acur Provision For Sales Returns
ProvisionForSalesReturns
83000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
6091000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1787000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2550000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
72000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
211000 USD
acur Provision For Sales Returns
ProvisionForSalesReturns
253000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
10873000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2811000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
10801000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-909000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
1671000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
1160000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
86000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
171000 USD
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
0 USD
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
64000 USD
CY2016Q3 acur Accrued Other Professional Fees Current
AccruedOtherProfessionalFeesCurrent
44000 USD
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
2000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
17000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
7000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-2000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-20000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
14000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
8000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-175000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
175000 USD
acur Proceeds From Market Offering Of Shares
ProceedsFromMarketOfferingOfShares
225000 USD
acur Proceeds From Market Offering Of Shares
ProceedsFromMarketOfferingOfShares
0 USD
CY2016Q3 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
2500000 USD
CY2016Q3 acur Cash Cash Equivalent And Marketable Securities
CashCashEquivalentAndMarketableSecurities
1800000 USD
CY2015Q2 us-gaap Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
250000 USD
CY2015Q4 acur Sales Returns Liability
SalesReturnsLiability
205000 USD
CY2016Q3 acur Sales Returns Liability
SalesReturnsLiability
288000 USD
CY2015Q1 us-gaap Cost Of Revenue
CostOfRevenue
255000 USD
CY2015Q1 us-gaap Deferred Sales Inducements Additions
DeferredSalesInducementsAdditions
314000 USD
CY2015Q4 acur Available For Sale Securities Debt Maturities After One Through Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue
400000 USD
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
3100000 USD
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
10900000 USD
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
100000 USD
CY2016Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
358000 USD
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
346000 USD
CY2016Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
98000 USD
CY2015Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
0 USD
CY2016Q3 us-gaap Inventory Gross
InventoryGross
456000 USD
CY2015Q4 us-gaap Inventory Gross
InventoryGross
346000 USD
CY2016Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
32000 USD
CY2015Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
47000 USD
CY2015Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
70000 USD
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 USD
acur Inventory Reserve Expense Raw And Packagings
InventoryReserveExpenseRawAndPackagings
0 USD
acur Inventory Reserve Expense Raw And Packagings
InventoryReserveExpenseRawAndPackagings
260000 USD
acur Inventory Reserve Expense Finished Goods
InventoryReserveExpenseFinishedGoods
26000 USD
acur Inventory Reserve Expense Finished Goods
InventoryReserveExpenseFinishedGoods
47000 USD
acur Inventory Destruction Raw And Packaging Material
InventoryDestructionRawAndPackagingMaterial
0 USD
acur Inventory Destruction Raw And Packaging Material
InventoryDestructionRawAndPackagingMaterial
260000 USD
acur Inventory Destruction Finished Goods
InventoryDestructionFinishedGoods
64000 USD
acur Inventory Destruction Finished Goods
InventoryDestructionFinishedGoods
0 USD
us-gaap Depreciation
Depreciation
92000 USD
us-gaap Depreciation
Depreciation
104000 USD
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1842000 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1741000 USD
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2821000 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2754000 USD
CY2016Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
86000 USD
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
101000 USD
CY2016Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
198000 USD
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
171000 USD
CY2015Q4 acur Accrued Other Professional Fees Current
AccruedOtherProfessionalFeesCurrent
92000 USD
CY2016Q3 acur Marketing Advertising And Promotion
MarketingAdvertisingAndPromotion
35000 USD
CY2015Q4 acur Marketing Advertising And Promotion
MarketingAdvertisingAndPromotion
115000 USD
CY2015Q3 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
16000 USD
CY2016Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
20000 USD
CY2016Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
28000 USD
CY2016Q3 acur Accrued Cost Sharing Expenses
AccruedCostSharingExpenses
325000 USD
CY2015Q4 acur Accrued Cost Sharing Expenses
AccruedCostSharingExpenses
0 USD
CY2013Q4 acur Debt Default Long Term Debt Percentage
DebtDefaultLongTermDebtPercentage
0.1335 pure
CY2013Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
10000000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.024 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.92 pure
CY2015Q3 acur Interest Expense Debt Discount
InterestExpenseDebtDiscount
31000 USD
CY2016Q3 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
12000 USD
CY2015Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
236000 USD
CY2016Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
651000 USD
CY2016Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2741000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2015Q1 acur Debt Instrument Cash Maintenance
DebtInstrumentCashMaintenance
2500000 USD
CY2016Q3 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
50000 USD
acur Debt Consulting Placement Fee
DebtConsultingPlacementFee
100000 USD
acur Debt Instrument Classification Amount
DebtInstrumentClassificationAmount
0 USD
CY2016Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
6370000 USD
acur Additions To Debt Instrument Unamortized Discount
AdditionsToDebtInstrumentUnamortizedDiscount
0 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
74000 USD
CY2016Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
119000 USD
CY2015Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
193000 USD
CY2015Q4 acur Debt Instrument Issuance Costs
DebtInstrumentIssuanceCosts
97000 USD
acur Amortization Expense Of Debt Instrument Issuance Costs
AmortizationExpenseOfDebtInstrumentIssuanceCosts
39000 USD
CY2016Q3 us-gaap Long Term Debt
LongTermDebt
6193000 USD
CY2016Q3 acur Debt Instrument Issuance Costs
DebtInstrumentIssuanceCosts
58000 USD
acur Interest Expense Debt Discount
InterestExpenseDebtDiscount
74000 USD
acur Interest Expense Debt Discount
InterestExpenseDebtDiscount
94000 USD
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
39000 USD
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
50000 USD
CY2016Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
180000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
584000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
748000 USD
CY2016Q3 acur Interest Expense Debt Discount
InterestExpenseDebtDiscount
23000 USD
CY2016Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2978000 USD
CY2013Q4 us-gaap Secured Debt
SecuredDebt
10000000 USD
CY2016Q3 acur Share Based Compensation Expense Recognized In Operations
ShareBasedCompensationExpenseRecognizedInOperations
150000 USD
CY2015Q3 acur Share Based Compensation Expense Recognized In Operations
ShareBasedCompensationExpenseRecognizedInOperations
150000 USD
acur Share Based Compensation Expense Recognized In Operations
ShareBasedCompensationExpenseRecognizedInOperations
450000 USD
acur Share Based Compensation Expense Recognized In Operations
ShareBasedCompensationExpenseRecognizedInOperations
461000 USD
acur Share Based Compensation Arrangement Share Based Payment Shares Reserved For Future Distribution
ShareBasedCompensationArrangementShareBasedPaymentSharesReservedForFutureDistribution
2400 shares
CY2016Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
23800 USD
CY2015 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
52800000 USD
CY2015Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
155200000 USD
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2015 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
2000000 USD
CY2016Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
11834000 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
11653000 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
11833000 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
10432000 shares
CY2016Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
46000 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
24000 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
25000 shares
CY2015Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
21000 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5000 USD
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
91000 USD
CY2016Q3 acur Debt Instrument Issuance Cost
DebtInstrumentIssuanceCost
58000 USD
CY2015Q4 acur Debt Instrument Issuance Cost
DebtInstrumentIssuanceCost
97000 USD
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
965000 shares
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1280000 shares
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
965000 shares
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11834000 shares
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11834000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11801000 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11801000 shares
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
3523000 USD
acur Proceeds From Registered Direct Offering
ProceedsFromRegisteredDirectOffering
0 USD
acur Proceeds From Registered Direct Offering
ProceedsFromRegisteredDirectOffering
7636000 USD
acur Payments Of Transaction Costs From Registered Direct Offering
PaymentsOfTransactionCostsFromRegisteredDirectOffering
0 USD
acur Payments Of Transaction Costs From Registered Direct Offering
PaymentsOfTransactionCostsFromRegisteredDirectOffering
603000 USD
acur Agreement Termination Notice Description
AgreementTerminationNoticeDescription
Egalet may terminate the Egalet Agreement for convenience on 120 days prior written notice, which termination may not occur prior to the second anniversary of Egalets launch of Oxaydo. Termination does not affect a partys rights accrued prior thereto, but there are no stated payments in connection with termination other than payments of obligations previously accrued. For all terminations (but not expiration), the Egalet Agreement provides for the transition of development and marketing of Oxaydo from Egalet to us, including the conveyance by Egalet to us of the trademarks and all regulatory filings and approvals relating to Oxaydo, and for Egalets supply of Oxaydo for a transition period.
CY2016Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1500000 USD
CY2014Q2 us-gaap Retail Related Inventory
RetailRelatedInventory
260000 USD
CY2015Q3 us-gaap Retail Related Inventory
RetailRelatedInventory
260000 USD
acur Inventory Reserve Expense
InventoryReserveExpense
96000 USD
acur Inventory Reserve Expense
InventoryReserveExpense
307000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
6000 USD
CY2016Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
351000 USD
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
517000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
362000 USD
CY2016Q3 acur Accrued Cost Sharing Expenses Post Marketing Study
AccruedCostSharingExpensesPostMarketingStudy
200000 USD
CY2016Q3 acur Accrued Cost Sharing Expenses Clinical Studies
AccruedCostSharingExpensesClinicalStudies
100000 USD

Files In Submission

Name View Source Status
0001144204-16-134413-index-headers.html Edgar Link pending
0001144204-16-134413-index.html Edgar Link pending
0001144204-16-134413.txt Edgar Link pending
0001144204-16-134413-xbrl.zip Edgar Link pending
acur-20160930.xml Edgar Link completed
acur-20160930.xsd Edgar Link pending
acur-20160930_cal.xml Edgar Link unprocessable
acur-20160930_def.xml Edgar Link unprocessable
acur-20160930_lab.xml Edgar Link unprocessable
acur-20160930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v450603_10q.htm Edgar Link pending
v450603_ex31-1.htm Edgar Link pending
v450603_ex31-2.htm Edgar Link pending
v450603_ex32-1.htm Edgar Link pending